"Postmenopause" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.
| Descriptor ID |
D017698
|
| MeSH Number(s) |
G08.686.157.500.625 G08.686.841.249.500.625
|
| Concept/Terms |
Postmenopause- Postmenopause
- Postmenopausal Period
- Period, Postmenopausal
- Post-Menopause
- Post Menopause
- Post-Menopauses
- Post-menopausal Period
- Period, Post-menopausal
- Post menopausal Period
|
Below are MeSH descriptors whose meaning is more general than "Postmenopause".
Below are MeSH descriptors whose meaning is more specific than "Postmenopause".
This graph shows the total number of publications written about "Postmenopause" by people in this website by year, and whether "Postmenopause" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 5 | 0 | 5 |
| 2001 | 3 | 1 | 4 |
| 2002 | 2 | 4 | 6 |
| 2003 | 1 | 5 | 6 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 4 | 4 |
| 2010 | 1 | 2 | 3 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 2 | 4 |
| 2013 | 2 | 2 | 4 |
| 2014 | 2 | 1 | 3 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 2 | 3 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Postmenopause" by people in Profiles.
-
Sexual Dysfunction After Menopause: Guidelines for Assessment and Management. Obstet Gynecol Clin North Am. 2024 Jun; 51(2):341-364.
-
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371.
-
Association of Acculturation and Hispanic/Latino Background with Endogenous Sex and Thyroid-Related Hormones Among Middle-Aged and Older Hispanic/Latino Adults: the HCHS/SOL Study. J Racial Ethn Health Disparities. 2024 Oct; 11(5):3040-3055.
-
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing. Cell Rep. 2022 12 20; 41(12):111838.
-
NT-pro B-type natriuretic peptide, early menopause, and incident heart failure in postmenopausal women of the ARIC study. Menopause. 2022 01 14; 29(3):309-316.
-
Gastrointestinal Evaluation of Iron Deficiency Anemia. JAMA. 2021 Oct 26; 326(16):1624-1625.
-
High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study. Menopause. 2021 01 04; 28(3):284-291.
-
Variation in outcome reporting and measurement tools in clinical trials of treatments for genitourinary symptoms in peri- and postmenopausal women: a systematic review. Menopause. 2020 09; 27(9):1070-1080.
-
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer. Breast Cancer Res. 2020 02 18; 22(1):22.
-
Epithelioid Trophoblastic Tumor: Expanding the Clinicopathologic Spectrum of a Rare Malignancy. Int J Gynecol Pathol. 2020 Jan; 39(1):8-18.